论文信息 - Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements - 字舞流文

Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

Myeloid neoplasms with KMT2A (

G. Garcia-Manero | T. Kadia | F. Ravandi | S. Pierce | L. Medeiros | Sa A. Wang | S. Konoplev | B. Thakral | G. Tang | R. Hasserjian | O. Pozdnyakova | D. Hammond | K. Sasaki | G. Montalban-Bravo | H. Kantarjian | N. Daver | G. Issa | K. Chien | Maria Siddiqui | Naval G Daver

[1] B. Ebert,et al. Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. , 2022, Blood.

[2] M. Loh,et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. , 2022, Blood.

[3] Y. Natkunam,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[4] M. Konopleva,et al. Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3) , 2020, American journal of hematology/oncology.

[5] E. Clappier,et al. The MLL recombinome of acute leukemias in 2017 , 2017, Leukemia.

[6] M. Stanulla. Application of the International Prognostic Scoring System- Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia , 2014 .

[7] F. Stingo,et al. Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia , 2014, Leukemia.